<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 6)
Quorum Health Group, Inc
-------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $.01 per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
749084109
-----------------------------------------------------
(CUSIP Number)
David J. Greenwald, Esq.
Goldman, Sachs & Co.
85 Broad Street
New York, New York 10004
(212) 902-1000
--------------------------------------------
(Name, address and telephone number of person authorized
to receive notices and communications)
October 29, 1996
- --------------------------------------------------------------------------------
(Date of Event which requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b) (3) or (4), check the following box: _____
Check the following box if a fee is being paid with this statement: ____
Page 1
<PAGE>
- -----------------
CUSIP NO.
749084109
- ----------
- --------------------------------------------------------------------------------
1. Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
GS Capital Partners, L.P.
- --------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group
(a) _____
(b) _____
- --------------------------------------------------------------------------------
3. SEC Use Only
- --------------------------------------------------------------------------------
4. Source of Funds
- --------------------------------------------------------------------------------
5. Check Box if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e)
- --------------------------------------------------------------------------------
6. Citizenship or place of Organization
Delaware
- --------------------------------------------------------------------------------
Number of 7 Sole Voting Power
Shares
Beneficially -0-
-------------------------
Owned By 8 Shared Voting Power
Each
Reporting 11,712
-------------------------
Person With 9 Sole Dispositive Power
-0-
-------------------------
10 Shared Dispositive Power
11,712
-------------------------
11. Aggregate Amount Beneficially Owned by Each Reporting Person
11,712
- --------------------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares
/ /
-------
- --------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11)
0.0%
- --------------------------------------------------------------------------------
14. Type of Reporting Person
PN
- --------------------------------------------------------------------------------
Page 2
<PAGE>
- ----------------------
CUSIP NO.
749084109
- -----------
- --------------------------------------------------------------------------------
1. Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
GS Advisors, L.P.
- --------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group
(a) _____
(b) _____
- --------------------------------------------------------------------------------
3. SEC Use Only
- --------------------------------------------------------------------------------
4. Source of Funds
- --------------------------------------------------------------------------------
5. Check Box if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e)
- --------------------------------------------------------------------------------
6. Citizenship or place of Organization
Delaware
- -----------------------------------------
Number of 7 Sole Voting Power
Shares
Beneficially -0-
----------------------
Owned By 8 Shared Voting Power
Each
Reporting 11,712
----------------------
Person With 9 Sole Dispositive Power
-0-
----------------------
10 Shared Dispositive Power
11,712
----------------------
11. Aggregate Amount Beneficially Owned by Each Reporting Person
11,712
- --------------------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares
/ /
------
- --------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11)
0.0%
- --------------------------------------------------------------------------------
14. Type of Reporting Person
PN
- --------------------------------------------------------------------------------
Page 3
<PAGE>
- ------------------------
CUSIP NO.
749084109
- ----------
- --------------------------------------------------------------------------------
1. Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Goldman, Sachs & Co.
- --------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group
(a) _____
(b) _____
- --------------------------------------------------------------------------------
3. SEC Use Only
- --------------------------------------------------------------------------------
4. Source of Funds
- --------------------------------------------------------------------------------
5. Check Box if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e)
- --------------------------------------------------------------------------------
6. Citizenship or place of Organization
New York
- -----------------------------------------
Number of 7 Sole Voting Power
Shares
Beneficially -0-
----------------------
Owned By 8 Shared Voting Power
Each
Reporting 2,249,073
----------------------
Person With 9 Sole Dispositive Power
-0-
----------------------
10 Shared Dispositive Power
2,249,073
- --------------------------------------------------------------------------------
11. Aggregate Amount Beneficially Owned by Each Reporting Person
2,249,073
- --------------------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares
/ /
-------
- --------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11)
4.6%
- --------------------------------------------------------------------------------
14. Type of Reporting Person
BD-PN
- --------------------------------------------------------------------------------
Page 4
<PAGE>
- ----------------------
CUSIP NO.
749084109
- -----------
- --------------------------------------------------------------------------------
1. Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
The Goldman Sachs Group, L.P.
- --------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group
(a) _____
(b) _____
- --------------------------------------------------------------------------------
3. SEC Use Only
- --------------------------------------------------------------------------------
4. Source of Funds
- --------------------------------------------------------------------------------
5. Check Box if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e)
- --------------------------------------------------------------------------------
6. Citizenship or place of Organization
Delaware
- -----------------------------------------
Number of 7 Sole Voting Power
Shares
Beneficially 1,228,315
------------------------------
Owned By 8 Shared Voting Power
Each
Reporting 2,249,073
------------------------------
Person With 9 Sole Dispositive Power
1,228,315
------------------------------
10 Shared Dispositive Power
2,249,073
- --------------------------------------------------------------------------------
11. Aggregate Amount Beneficially Owned by Each Reporting Person
3,477,388
- --------------------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares
/ /
------
- --------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11)
7.1%
- --------------------------------------------------------------------------------
14. Type of Reporting Person
HC-PN
- --------------------------------------------------------------------------------
Page 5
<PAGE>
AMENDMENT NO. 6 TO
SCHEDULE 13D
RELATING TO THE COMMON STOCK OF
QUORUM HEALTH GROUP, INC.
GS Capital Partners, L.P. ("GSCP"), GS Advisors, L.P. ("GS Advisors,
L.P."), Goldman, Sachs & Co. ("Goldman Sachs") and The Goldman Sachs Group, L.P.
("GS Group" and together with GSCP, GS Advisors, L.P. and Goldman Sachs, the
"Filing Persons")/*/ hereby amend the statement on Schedule 13D filed with
respect to the common stock, par value $.01 per share (the "Common Stock"), of
Quorum Health Group, Inc., a Delaware corporation (the "Company"), as most
recently amended by Amendment No. 5 thereto dated October 30, 1996 (as amended,
the "Schedule 13D"). Unless otherwise indicated, all capitalized terms used but
not defined herein shall have the same meaning ascribed to them in the Schedule
13D.
This Amendment No. 6 is being filed to change the description of the
Distribution described in Amendment No. 5 to reflect that GSCP distributed to
its partners on a pro rata basis in accordance with its partnership agreement
2,916,204 shares owned by GSCP, and after the Distribution, GSCP owned 46 Shares
of Common Stock.
Item 2 is hereby amended as follows:
Item 2. Identity and Background.
-----------------------
GS Group and Goldman Sachs may be deemed, for purposes of this Schedule
13D, to own beneficially 2,249,073 shares of Common Stock, including (i) shares
of Common Stock owned by certain limited partnerships (the "Other Limited
Partnerships") of which affiliates of Goldman Sachs and GS Group are the general
partner or the managing general partner, (ii) shares of Common Stock held by
Goldman Sachs in connection with its ordinary course trading activities, (iii)
shares of Common Stock currently held in managed accounts (the "Managed
Accounts") for which Goldman Sachs exercises voting and/or investment authority,
and (iv) shares of Common Stock owned by GSCP and shares of Common Stock that
may be purchased pursuant to options beneficially owned by GSCP that are
currently exercisable or that may be exercised within 60 days (as described in
Item 5
- --------------------------
/*/ Neither the present filing nor anything contained herein shall be construed
as an admission that Goldman Sachs, GS Group or any of the partnerships
constitute a "person" for any purpose other than Section 13(d) of the
Securities Exchange Act of 1934.
<PAGE>
below). In addition, GS Group beneficially owns 1,228,315 shares of Common
Stock, including the shares of Common Stock received by it in connection with
the Distribution described in Item 4 below and shares of Common Stock that may
be purchased pursuant to options beneficially owned by GS Group that are
currently exercisable (as described in Item 5 below). Goldman Sachs and GS Group
each disclaims beneficial ownership of shares of Common Stock (i) owned by the
Other Limited Partnerships and GSCP to the extent of partnership interests in
the Other Limited Partnerships and GSCP held by persons other than Goldman
Sachs, GS Group or their affiliates and (ii) held in Managed Accounts.
Item 3 is hereby amended as follows:
Item 3. Source and Amount of Funds or Other Consideration.
-------------------------------------------------
See Schedule IV hereto for transactions in the Common Stock which have been
effected since October 29, 1996, the date through which transactions were
disclosed in Amendment No. 5 to this Schedule 13D. The total consideration
(exclusive of commissions) for shares of Common Stock purchased since October
29, 1996 is $9,700,098. All such transactions were effected in the ordinary
course of business of Goldman Sachs. Funds for the purchases made in ordinary
course trading activities by Goldman Sachs came from working capital. Funds for
the purchase of shares of Common Stock held in Managed Accounts came from client
funds. No consideration was paid by any distributee in connection with the
Distribution described in Item 4 below.
Item 4 is hereby amended as follows:
Item 4. Purpose of the Transaction.
--------------------------
On October 29, 1996, GSCP distributed (the "Distribution") 2,916,204 shares
of Common Stock owned by GSCP to its partners on a pro rata basis in accordance
--- ----
with GSCP's partnership agreement. The shares distributed to the partners (other
than the partners, if any, who are
<PAGE>
"affiliates" of the Company (as such term is defined under the Securities Act))
are salable without registration under the Securities Act and without regard to
the requirements of Rule 144 under the Securities Act, and the shares
distributed to any partner which is an affiliate of the Company are salable
pursuant to Rule 144. In order to avoid distribution of fractional shares, GSCP
retained 46 shares of Common Stock.
Item 5 is hereby amended as follows:
Item 5. Interest in Securities of the Issuer.
------------------------------------
As described in Item 4 above, on October 29, 1996, GSCP distributed
shares of Common Stock owned by GSCP to its partners on a pro rata basis in
accordance with GSCP's partnership agreement. As of November 5, 1996, GSCP
beneficially owned and GS Advisors, L.P. may be deemed to beneficially own
11,712 shares of Common Stock, representing less than 1% of the outstanding
shares of Common Stock, including 11,666 shares of Common Stock that may be
purchased pursuant to options that are currently exercisable or that may be
exercised within 60 days. These options were issued by the Company to an
officer of Goldman Sachs in his capacity as a director of the Company. This
officer has an agreement with Goldman Sachs pursuant to which he holds the
options for the benefit of GSCP, and such options may therefore be deemed to
be beneficially owned by GSCP and GS Advisors, L.P. As of November 5, 1996,
Goldman Sachs may be deemed to beneficially own a total of 2,249,073 shares of
Common Stock (representing approximately 4.6% of the Common Stock reported to be
outstanding (as indicated in the Company's Form 10-K for the fiscal year ended
June 30, 1996)), including 546,252 shares owned by the Other Limited
Partnerships, 104 shares of Common Stock held by Goldman Sachs in connection
with its ordinary course trading activities, 1,691,005 shares held in Managed
Accounts and 11,712 shares beneficially owned by GSCP as described above. GS
Group may be deemed to beneficially own the 2,249,073 shares of Common Stock
beneficially owned by Goldman Sachs. As of November 5, 1996, GS Group also
beneficially owned 1,227,482 shares of Common Stock it received in the
Distribution and 833 shares of Common Stock that may be purchased pursuant to
options that are currently exercisable. These options were issued by the Company
to an officer of Goldman Sachs in his capacity as a director of the Company.
This officer has an agreement with GS Group pursuant to which he holds these
options for the benefit of GS Group, and such options may therefore be deemed to
be beneficially owned by GS Group. Accordingly, as of November 5, 1996, GS Group
may be deemed to beneficially
<PAGE>
own an aggregate of 3,477,388 shares of Common Stock (representing approximately
7.1% of the Common Stock reported to be outstanding (as indicated in the
Company's Form 10-K for the fiscal year ended June 30, 1996)). Goldman Sachs and
GS Group each disclaims beneficial ownership of shares of Common Stock (i) owned
by the Other Limited Partnerships and GSCP to the extent of partnership
interests in the Other Limited Partnerships and GSCP held by persons other than
Goldman Sachs, GS Group or their affiliates and (ii) held in Managed Accounts.
None of the Filing Persons and, to the knowledge of each of the Filing Persons,
none of the Other Limited Partnerships that is not a Filing Person beneficially
owns any shares of Common Stock other than as set forth herein.
(b) Each Filing Person has the power to vote or to direct the vote and
to dispose or to direct the disposition of shares of Common Stock beneficially
owned by such Filing Person as indicated in pages 2 through 5 above.
(c) See Schedule IV hereto for transactions in the Common Stock which
have been effected since October 29, 1996, the date through which transactions
were disclosed in Amendment No. 5 to this Schedule 13D. All such transactions
were effected in the ordinary course of business of Goldman Sachs. The
transactions in Common Stock described in Schedule IV were effected on the
NASDAQ National Market. The total consideration (exclusive of commissions) for
shares of Common Stock purchased since October 29, 1996 is $9,700,098.
(e) On October 29, 1996, each of GSCP, GS Advisors, L.P. and Goldman
Sachs ceased to be the beneficial owner of more than 5% of the Common Stock.
<PAGE>
SIGNATURE
---------
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
GS CAPITAL PARTNERS, L.P.
By: GS Advisors, L.P., its general partner
BY: GS Advisors, Inc., its general partner
By: /s/ Richard A. Friedman
------------------------------------------
Name: Richard A. Friedman
Title: President
Dated: November 6, 1996
<PAGE>
SIGNATURE
---------
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
GS ADVISORS, L.P.
BY: GS Advisors, Inc., its general partner
By: /s/ Richard A. Friedman
------------------------------------------
Name: Richard A. Friedman
Title: President
Dated: November 6, 1996
<PAGE>
SIGNATURE
---------
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
GOLDMAN, SACHS & CO.
By: /s/ Richard A. Friedman
------------------------------------------
Name: Richard A. Friedman
Title: Partner
Dated: November 6, 1996
<PAGE>
SIGNATURE
---------
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
THE GOLDMAN SACHS GROUP, L.P.
By: /s/ Richard A. Friedman
------------------------------------------
Name: Richard A. Friedman
Title: Partner
Dated: November 6, 1996
<PAGE>
SCHEDULE IV
-----------
Quorum Health Group, Inc.
Cusip: 749084-10-9
<TABLE>
<CAPTION>
Reference No. Purchase Sale Price Td Date Sttle. Date
<S> <C> <C> <C> <C> <C>
1031-143032-12 9,190 26 7/8 31-Oct-96 5-Nov-96
1030-016783-13 2,500 27 1/4 30-Oct-96 4-Nov-96
1030-016784-13 7,500 27 1/4 30-Oct-96 4-Nov-96
1030-017047-13 2,976 27 5/8 30-Oct-96 4-Nov-96
1030-017048-13 7,000 27 1/2 30-Oct-96 4-Nov-96
1030-017049-13 1,000 27 3/8 30-Oct-96 4-Nov-96
1030-017050-13 1,000 27 1/4 30-Oct-96 4-Nov-96
1030-017051-13 11,000 27 30-Oct-96 4-Nov-96
1030-017134-13 3,785 27 1/2 30-Oct-96 4-Nov-96
1030-017135-13 1,000 27 3/8 30-Oct-96 4-Nov-96
1030-017136-13 1,000 27 1/4 30-Oct-96 4-Nov-96
1030-017137-13 8,000 27 30-Oct-96 4-Nov-96
1030-017151-13 22,976 27 1/16 30-Oct-96 4-Nov-96
1030-017324-13 2,500 27 1/4 30-Oct-96 4-Nov-96
1030-020461-12 1,000 27 3/4 30-Oct-96 4-Nov-96
1030-021971-12 700 27 3/4 30-Oct-96 4-Nov-96
1030-021972-12 2,500 27 3/4 30-Oct-96 4-Nov-96
1030-021984-12 1,000 27 3/4 30-Oct-96 4-Nov-96
1030-021989-12 1,000 27 3/4 30-Oct-96 4-Nov-96
1030-022126-12 5,000 27 3/4 30-Oct-96 4-Nov-96
1030-022376-12 3,500 27 5/8 30-Oct-96 4-Nov-96
1030-022385-12 1,000 27 5/8 30-Oct-96 4-Nov-96
1030-022392-12 1,000 27 5/8 30-Oct-96 4-Nov-96
1030-022417-12 5,000 27 1/2 30-Oct-96 4-Nov-96
1030-022423-12 1,000 27 1/2 30-Oct-96 4-Nov-96
1030-022431-12 1,000 27 1/2 30-Oct-96 4-Nov-96
1030-022432-12 1,000 27 1/2 30-Oct-96 4-Nov-96
1030-022507-12 1,000 27 3/8 30-Oct-96 4-Nov-96
1030-022514-12 1,000 27 1/4 30-Oct-96 4-Nov-96
1030-022519-12 5,000 27 1/4 30-Oct-96 4-Nov-96
1030-022534-12 1,000 27 1/4 30-Oct-96 4-Nov-96
1030-022538-12 1,000 27 1/4 30-Oct-96 4-Nov-96
1030-022741-12 1,000 27 1/4 30-Oct-96 4-Nov-96
1030-022862-12 10,000 27 3/16 30-Oct-96 4-Nov-96
1030-022965-12 5,000 27 3/16 30-Oct-96 4-Nov-96
1030-023527-12 1,000 27 3/16 30-Oct-96 4-Nov-96
1030-023530-12 3,000 27 3/16 30-Oct-96 4-Nov-96
1030-024128-12 1,000 27 1/4 30-Oct-96 4-Nov-96
1030-100787-13 50,000 27 1/4 30-Oct-96 4-Nov-96
1030-112522-13 11,488 27 1/8 30-Oct-96 4-Nov-96
1030-260588-13 6,892 27 1/8 30-Oct-96 4-Nov-96
1030-270621-13 10,000 27.438 30-Oct-96 4-Nov-96
1030-300784-13 1,000 27 5/16 30-Oct-96 4-Nov-96
1030-300785-13 1,000 27 3/16 30-Oct-96 4-Nov-96
1030-300786-13 2,595 26 15/16 30-Oct-96 4-Nov-96
</TABLE>
Page 1 of 4
<PAGE>
Quorum Health Group, Inc.
Cusip: 749084-10-9
<TABLE>
<CAPTION>
Reference No. Purchase Sale Price Td Date Sttle. Date
<S> <C> <C> <C> <C> <C>
1031-016610-13 2,500 27 1/4 31-Oct-96 5-Nov-96
1031-016611-13 1,000 27 1/4 31-Oct-96 5-Nov-96
1031-016612-13 1,000 27 1/4 31-Oct-96 5-Nov-96
1031-016613-13 1,000 27 1/4 31-Oct-96 5-Nov-96
1031-016614-13 1,000 27 1/4 31-Oct-96 5-Nov-96
1031-016615-13 1,000 27 1/4 31-Oct-96 5-Nov-96
1031-016819-13 308 27.455 31-Oct-96 5-Nov-96
1031-021311-12 5,000 27 1/8 31-Oct-96 5-Nov-96
1031-023823-12 1,200 26 7/8 31-Oct-96 5-Nov-96
1031-024131-12 1,300 26 7/8 31-Oct-96 5-Nov-96
1031-024136-12 2,000 26 7/8 31-Oct-96 5-Nov-96
1031-024494-12 2,000 26 7/8 31-Oct-96 5-Nov-96
1031-025529-12 1,400 27 31-Oct-96 5-Nov-96
1031-025536-12 1,000 27 31-Oct-96 5-Nov-96
1031-105500-13 1,000 27 1/8 31-Oct-96 5-Nov-96
1031-105501-13 22,500 27 1/8 31-Oct-96 5-Nov-96
1031-105502-13 1,500 27 1/8 31-Oct-96 5-Nov-96
1031-105529-13 10,000 26 7/8 31-Oct-96 5-Nov-96
1031-120041-13 9,190 27 3/16 31-Oct-96 5-Nov-96
1031-143032-13 9,190 26 7/8 31-Oct-96 5-Nov-96
1031-206240-13 8,000 26 7/8 31-Oct-96 5-Nov-96
1031-206241-13 200 26 7/8 31-Oct-96 5-Nov-96
1031-206242-13 500 26 7/8 31-Oct-96 5-Nov-96
1031-206243-13 1,300 26 7/8 31-Oct-96 5-Nov-96
1031-206594-13 5,000 27 1/8 31-Oct-96 5-Nov-96
1031-206633-13 1,500 26 7/8 31-Oct-96 5-Nov-96
1031-206634-13 1,900 26 7/8 31-Oct-96 5-Nov-96
8031-334104-13 1,488 27 1/8 31-Oct-96 5-Nov-96
1101-001145-13 8,000 26 7/8 1-Nov-96 6-Nov-96
1101-001146-13 1,000 26 7/8 1-Nov-96 6-Nov-96
1101-001147-13 1,000 26 7/8 1-Nov-96 6-Nov-96
1101-001148-13 500 26 7/8 1-Nov-96 6-Nov-96
1101-022847-12 5,000 26 3/4 1-Nov-96 6-Nov-96
1101-022848-12 1,000 26 3/4 1-Nov-96 6-Nov-96
1101-022898-12 1,000 26 3/8 1-Nov-96 6-Nov-96
1101-022983-12 800 26 1/4 1-Nov-96 6-Nov-96
1101-023171-12 1,500 26 1/8 1-Nov-96 6-Nov-96
1101-023570-12 5,000 26 1/4 1-Nov-96 6-Nov-96
1101-023591-12 5,000 26 1/4 1-Nov-96 6-Nov-96
1101-025320-12 600 26 1/4 1-Nov-96 6-Nov-96
1101-025321-12 500 26 5/16 1-Nov-96 6-Nov-96
1101-025328-12 1,000 26 3/8 1-Nov-96 6-Nov-96
1101-025378-12 1,000 26 1/2 1-Nov-96 6-Nov-96
1101-025472-12 400 26 1/2 1-Nov-96 6-Nov-96
1101-105665-13 77,500 26.6008 1-Nov-96 6-Nov-96
1101-110299-13 6,600 26 1/2 1-Nov-96 6-Nov-96
1101-111074-13 12,000 26 1/2 1-Nov-96 6-Nov-96
1101-190395-13 22,100 26 3/8 1-Nov-96 6-Nov-96
1101-190396-13 600 26 3/8 1-Nov-96 6-Nov-96
1101-190397-13 1,400 26 3/8 1-Nov-96 6-Nov-96
</TABLE>
Page 2 of 4
<PAGE>
Quorum Health Group, Inc.
Cusip: 749084-10-9
<TABLE>
<CAPTION>
Reference No. Purchase Sale Price Td Date Sttle. Date
<S> <C> <C> <C> <C> <C>
1101-190398-13 3,400 26 3/8 1-Nov-96 6-Nov-96
1101-190519-13 5,000 26 3/4 1-Nov-96 6-Nov-96
1101-190606-13 10,000 26 1/4 1-Nov-96 6-Nov-96
1101-266116-13 2,000 26 7/8 1-Nov-96 6-Nov-96
1101-274274-13 40,000 26 1/2 1-Nov-96 6-Nov-96
1101-274780-13 17,100 26 1/4 1-Nov-96 6-Nov-96
1101-280432-13 9,190 26 5/8 1-Nov-96 6-Nov-96
1101-300876-13 13,890 26 3/4 1-Nov-96 6-Nov-96
1104-022864-12 1,000 26 3/8 4-Nov-96 7-Nov-96
1104-022865-12 1,000 26 3/8 4-Nov-96 7-Nov-96
1104-023924-12 1,532 26 1/4 4-Nov-96 7-Nov-96
1104-023928-12 1,000 26 5/8 4-Nov-96 7-Nov-96
1104-023929-12 1,000 26 5/8 4-Nov-96 7-Nov-96
1104-023961-12 1,000 26 5/8 4-Nov-96 7-Nov-96
1104-024227-12 1,000 26 1/2 4-Nov-96 7-Nov-96
1104-024233-12 1,000 26 1/2 4-Nov-96 7-Nov-96
1104-024374-12 1,000 26 4-Nov-96 7-Nov-96
1104-024441-12 3,000 26 9/16 4-Nov-96 7-Nov-96
1104-024446-12 1,000 26 9/16 4-Nov-96 7-Nov-96
1104-024448-12 700 26 9/16 4-Nov-96 7-Nov-96
1104-105231-13 7,300 26 1/2 4-Nov-96 7-Nov-96
1104-105232-13 2,800 26 1/2 4-Nov-96 7-Nov-96
1104-105233-13 1,000 26 1/2 4-Nov-96 7-Nov-96
1104-105460-13 25,000 26 1/4 4-Nov-96 7-Nov-96
1104-190220-13 10,000 26 3/8 4-Nov-96 7-Nov-96
1104-190221-13 700 26 3/8 4-Nov-96 7-Nov-96
1104-190222-13 300 26 3/8 4-Nov-96 7-Nov-96
1104-190223-13 1,500 26 3/8 4-Nov-96 7-Nov-96
1104-266068-13 1,700 26 1/4 4-Nov-96 7-Nov-96
1104-274203-13 30,000 26.292 4-Nov-96 7-Nov-96
1104-274207-13 5,000 26 1/2 4-Nov-96 7-Nov-96
1104-304053-13 10,000 26 1/2 4-Nov-96 7-Nov-96
1105-334016-13 6,000 26 4-Nov-96 7-Nov-96
1105-334017-13 5,500 26 1/8 4-Nov-96 7-Nov-96
1105-334018-13 5,500 26 3/8 4-Nov-96 7-Nov-96
1105-334019-13 5,976 26 3/8 4-Nov-96 7-Nov-96
1105-022356-12 2,500 25 7/8 5-Nov-96 8-Nov-96
1105-022380-12 500 25 7/8 5-Nov-96 8-Nov-96
1105-022381-12 2,500 25 7/8 5-Nov-96 8-Nov-96
1105-022426-12 2,500 25 7/8 5-Nov-96 8-Nov-96
1105-022637-12 600 25 7/8 5-Nov-96 8-Nov-96
1105-022904-12 1,000 25 7/8 5-Nov-96 8-Nov-96
1105-023468-12 2,000 26 5-Nov-96 8-Nov-96
1105-023469-12 500 26 5-Nov-96 8-Nov-96
1105-023472-12 2,000 26 5-Nov-96 8-Nov-96
1105-023536-12 1,000 26 5-Nov-96 8-Nov-96
1105-023537-12 800 26 5-Nov-96 8-Nov-96
1105-025246-12 3,500 26 5-Nov-96 8-Nov-96
1105-025354-12 3,500 26 5-Nov-96 8-Nov-96
1105-190803-13 2,500 25 3/4 5-Nov-96 8-Nov-96
</TABLE>
Page 3 of 4
<PAGE>
Quorum Health Group, Inc.
Cusip: 749084-10-9
<TABLE>
<CAPTION>
Reference No. Purchase Sale Price Td Date Sttle. Date
<S> <C> <C> <C> <C> <C>
1105-190804-13 2,500 25 7/8 5-Nov-96 8-Nov-96
1105-190805-13 2,500 26 5-Nov-96 8-Nov-96
1105-286081-13 4,595 25 5/8 5-Nov-96 8-Nov-96
</TABLE>
Page 4 of 4
